Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis

A Bahji, D Ermacora, C Stephenson… - Journal of affective …, 2020 - Elsevier
Objective We investigated the comparative efficacy and tolerability of pharmacological
treatment strategies for the treatment of acute bipolar depression. Data sources A systematic …

Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis

MM Sidor, GM MacQueen - The Journal of clinical psychiatry, 2010 - psychiatrist.com
Objective: The role of antidepressants in the acute treatment of bipolar depression remains a
contentious issue. A previous meta-analysis of randomized controlled trials (RCTs) …

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …

LN Yatham, SH Kennedy, SV Parikh… - Bipolar …, 2018 - Wiley Online Library
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for …

LN Yatham, SH Kennedy, SV Parikh… - Bipolar …, 2013 - Wiley Online Library
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O'Donovan C,
MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN …

Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology

GM Goodwin, PM Haddad, IN Ferrier… - Journal of …, 2016 - journals.sagepub.com
The British Association for Psychopharmacology guidelines specify the scope and targets of
treatment for bipolar disorder. The third version is based explicitly on the available evidence …

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute …

H Grunze, E Vieta, GM Goodwin… - The World Journal of …, 2010 - Taylor & Francis
Objectives. These guidelines are based on a first edition that was published in 2002, and
have been edited and updated with the available scientific evidence until September 2009 …

Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study

A Loebel, J Cucchiaro, R Silva… - American Journal of …, 2014 - Am Psychiatric Assoc
Objective Few studies have been reported that support the efficacy of adjunctive therapy for
patients with bipolar I depression who have had an insufficient response to monotherapy …

The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments

R Machado-Vieira, J Baumann, C Wheeler-Castillo… - Pharmaceuticals, 2010 - mdpi.com
Currently available antidepressants used to treat major depressive disorder (MDD)
unfortunately often take weeks to months to achieve their full effects, commonly resulting in …

Bipolar disorder—focus on bipolar II disorder and mixed depression

F Benazzi - The Lancet, 2007 - thelancet.com
Bipolar II disorder (recurrent depressive and hypomanic episodes) and related disorders
(united in the bipolar spectrum) are understudied, despite a prevalence of about 5% in the …

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

M Berk, A Brnabic, S Dodd, K Kelin, M Tohen… - Bipolar …, 2011 - Wiley Online Library
Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD. Does
stage of illness impact treatment response in bipolar disorder? Empirical treatment data and …